January 4, 2021
Newsroom
Displaying 121–130 of 131
December 8, 2020
Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 4, 2020
Seer Announces Pricing of Initial Public Offering
September 15, 2020
Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing
September 15, 2020
Seer Appoints Catherine Friedman to its Board of Directors
July 22, 2020
Seers Announces Publication in Nature Communications Demonstrating Performance, Scalability and Utility of its Platform Technology for Deep, Unbiased Proteomics
July 22, 2020
Seer Announces $55M Financing Led by Fidelity Management and Research Company
May 19, 2020
Seer Announces Appointment of David R. Horn as Chief Financial Officer
May 12, 2020
Seer Announces Appointment of Omead Ostadan as President and Chief Operating Officer
December 17, 2019
Seer Announces $55 Million in Series D Equity Financing
No results found.
Starting your proteomics research is effortless
Connect with an expert to discuss which path to the full proteome is right for you.
-
Bring the Proteograph Product Suite in-house
-
Run a project with
Seer Technology
Access Center -
Conduct a project with
a Seer service provider
or Center of Excellence